Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bryostatin 1 in Metastatic Colorectal Cancer
NCT00003220Phase 2Completed
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Start
- Feb 1998
- Primary completion
- Nov 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bryostatin-1 in colorectal cancer (CRC), sponsored by Barbara Ann Karmanos Cancer Institute. Primary endpoint: Objective Response Rate. Started Feb 1998; status: completed.
02
Drugs
bryostatin-1
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00003220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003220.